Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd - Investor Relations & Filings

Listed IPO Sep 2021
Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 227 across all filing types
Latest filing 2026-05-27 Investor Presentation
Country KR South Korea
Listing KO 099430 · 1 venue

Key figures FY2025

Period ended 2025-12-31 · KRW
Headline annual figures for BioPlus Co., Ltd, fiscal year 2025, reported in KRW, with the source filing for each figure.
Total Revenues KRW 53.38B per the Audit Report / Information filed 2026-03-20
Net Income KRW 12.41B per the Audit Report / Information filed 2026-03-20
Total Assets KRW 253.67B per the Audit Report / Information filed 2026-03-20
Total Equity KRW 175.12B per the Audit Report / Information filed 2026-03-20
Cash from Ops KRW 11.51B per the Audit Report / Information filed 2026-03-20

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 80% confidence The document is an announcement detailing the scheduling, location, participants, and format of the company’s upcoming Investor Relations presentation (Non-Deal Roadshow). While it does not contain slide content itself, it clearly pertains to an IR event, fitting the Investor Presentation category rather than a financial report or other filing type.
2026-05-27 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled "분기보고서" (Quarterly Report) for the period January 1 2026 to March 31 2026 (the 1st quarter of the 24th business year). It includes detailed company overview, financial data, capital changes, share information, historical events, and other substantive disclosures. It clearly contains the full interim financial report itself rather than merely announcing or summarizing results. Therefore, it should be classified as an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-14 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the adjustment of the conversion price of convertible bonds, including specific numeric adjustments, dates, and the rationale behind the adjustment. It does not contain financial statements or comprehensive financial performance data. It is a regulatory announcement about a capital structure adjustment related to convertible bonds. The document length is short (2457 characters) and focuses on the adjustment details rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure through convertible bond conversion price adjustments.
2026-04-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 88% confidence The document is a regulatory notification titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고” (Notification of appointment, dismissal, or mid‐term resignation of outside directors). It provides details on an outside director’s resignation/dismissal (date, name, term, reason) and updated board composition. This clearly corresponds to a board/management change announcement, matching category “Board/Management Information (MANG).”
2026-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is titled “주식등의 대량보유상황보고서(일반)” (Report on Large Holdings of Stocks) and contains detailed schedules of shareholdings, changes in share numbers, related parties, and regulatory references under the Capital Markets Act. This corresponds exactly to a notification of significant share ownership changes. Hence, it matches the “Major Shareholding Notification” category (Code: MRQ).
2026-04-02 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 93% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange about the appointment (선임), dismissal, or mid‐term resignation of an outside director (사외이사). It provides details on board composition changes, effective date, and biographical information of the new outside director. This clearly matches the definition for Board/Management Information (announcement of changes in the board of directors).
2026-03-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.